Trademark: 97171270
Status Date
Tuesday, December 12, 2023
Filing Date
Tuesday, December 14, 2021
Published for Opposition
Tuesday, October 18, 2022
44 Medical testing services, namely, next generation sequencing tests for diagnosis, prognosis, and treatment of brain cancer and brain tumors; marking, separating, isolating, and sequencing and analysis of human tissue and human brain samples for diagnostic or treatment purposes
HIF SINGLE NUCLEUS RNA SEQUENCING, SINGLE NUCLEI RNA SEQUENCING
Dec 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 12, 2023
Sou Extension 2 Granted
Dec 12, 2023
Sou Extension 2 Filed
Dec 12, 2023
Sou Teas Extension Received
Jun 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 12, 2023
Sou Extension 1 Granted
Jun 12, 2023
Sou Extension 1 Filed
Jun 12, 2023
Sou Teas Extension Received
Dec 13, 2022
Noa E-Mailed - Sou Required From Applicant
Oct 18, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 18, 2022
Published For Opposition
Sep 28, 2022
Notification Of Notice Of Publication E-Mailed
Sep 13, 2022
Approved For Pub - Principal Register
Sep 6, 2022
Assigned To Examiner
Dec 17, 2021
New Application Office Supplied Data Entered
Dec 17, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
